Sodium-Coupled Neutral Amino Acid Transporter 1 (SNAT1) Modulates L-Citrulline Transport and Nitric Oxide (NO) Signaling in Piglet Pulmonary Arterial Endothelial Cells

Rationale There is evidence that impairments in nitric oxide (NO) signaling contribute to chronic hypoxia-induced pulmonary hypertension. The L-arginine-NO precursor, L-citrulline, has been shown to ameliorate pulmonary hypertension. Sodium-coupled neutral amino acid transporters (SNATs) are involved in the transport of L-citrulline into pulmonary arterial endothelial cells (PAECs). The functional link between the SNATs, L-citrulline, and NO signaling has not yet been explored. Objective We tested the hypothesis that changes in SNAT1 expression and transport function regulate NO production by modulating eNOS coupling in newborn piglet PAECs. Methods and Results A silencing RNA (siRNA) technique was used to assess the contribution of SNAT1 to NO production and eNOS coupling (eNOS dimer-to-monomer ratios) in PAECs from newborn piglets cultured under normoxic and hypoxic conditions in the presence and absence of L-citrulline. SNAT1 siRNA reduced basal NO production in normoxic PAECs and prevented L-citrulline-induced elevations in NO production in both normoxic and hypoxic PAECs. SNAT1 siRNA reduced basal eNOS dimer-to-monomer ratios in normoxic PAECs and prevented L-citrulline-induced increases in eNOS dimer-to-monomer ratios in hypoxic PAECs. Conclusions SNAT1 mediated L-citrulline transport modulates eNOS coupling and thus regulates NO production in hypoxic PAECs from newborn piglets. Strategies that increase SNAT1-mediated transport and supply of L-citrulline may serve as novel therapeutic approaches to enhance NO production in patients with pulmonary vascular disease.

[1]  C. Moinard,et al.  Citrulline: from metabolism to therapeutic use. , 2013, Nutrition.

[2]  R. Dweik,et al.  Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy , 2013, Pulmonary circulation.

[3]  M. Aschner,et al.  Prolonged hypoxia augments L-citrulline transport by system A in the newborn piglet pulmonary circulation. , 2012, Cardiovascular research.

[4]  Marshall Summar,et al.  Requirement of argininosuccinate lyase for systemic nitric oxide production , 2011, Nature Medicine.

[5]  P. V. Van Schil,et al.  Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. , 2011, Free radical biology & medicine.

[6]  D. Luo,et al.  L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats. , 2010, American journal of physiology. Endocrinology and metabolism.

[7]  D. Harrison,et al.  Therapeutic targeting of mitochondrial superoxide in hypertension , 2010, Circulation research.

[8]  M. Summar,et al.  L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[9]  R. Böger L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous? , 2008, Current opinion in clinical nutrition and metabolic care.

[10]  D. Kass,et al.  L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. , 2006, JAMA.

[11]  M. Asano,et al.  Nitric oxide formation and plasma L-arginine levels in pulmonary hypertensive rats. , 2004, Respiratory medicine.

[12]  J. Aschner,et al.  Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[13]  D. Eichler,et al.  The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells , 2003, Journal of Experimental Biology.

[14]  L. Sobrevia,et al.  Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. , 2003, Physiological reviews.

[15]  D. Eichler,et al.  Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. , 2001, Nitric oxide : biology and chemistry.

[16]  B. Nemery,et al.  Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[17]  R. T. Miller,et al.  The C331A Mutant of Neuronal Nitric-Oxide Synthase Is Defective in Arginine Binding* , 1998, The Journal of Biological Chemistry.

[18]  K. Maruyama,et al.  Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. , 1997, Circulation.

[19]  E. Block,et al.  Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary artery endothelial cells. , 1995, The American journal of physiology.

[20]  P. Klatt,et al.  Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L‐arginine in the formation of an SDS‐resistant dimer. , 1995, The EMBO journal.